The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic gastric cancer/gastroesophageal junction cancer (GC/GEJC).
 
Zhendong Chen
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Xiaoyan Lin
No Relationships to Disclose
 
Liu Yang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jun Wang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Honoraria - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Juan Zhang
No Relationships to Disclose
 
Fan Yu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Cong Fei
No Relationships to Disclose
 
Ruiqi Huang
No Relationships to Disclose
 
Jin Li
Honoraria - ArteMed Hospital
Consulting or Advisory Role - HenRui; Novartis
Speakers' Bureau - Boehringer Ingelheim; Lilly